Glucose transporter 1 expression as a marker of prognosis in oesophageal adenocarcinoma

BACKGROUND: The current TNM staging system for oesophageal adenocarcinoma (OAC) has limited ability to stratify patients and inform clinical management following neo-adjuvant chemotherapy and surgery. RESULTS: Functional genomic analysis of the gene expression data using Gene Set Enrichment Analysis...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Autores principales: Blayney, Jaine K., Cairns, Lauren, Li, Gerald, McCabe, Niamh, Stevenson, Leanne, Peters, Christopher J., Reid, Nathan B., Spence, Veronica J., Chisambo, Chintapuza, McManus, Damian, James, Jacqueline, McQuaid, Stephen, Craig, Stephanie, Arthur, Kenneth, McArt, Darragh, Ong, Chin-Ann J., Lao-Sirieix, Pierre, Hamilton, Peter, Salto-Tellez, Manuel, Eatock, Martin, Coleman, Helen G., Fitzgerald, Rebecca C., Kennedy, Richard D., Turkington, Richard C.
Formato: Artigo
Lenguaje:Inglês
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915089/
https://ncbi.nlm.nih.gov/pubmed/29719622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24906
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares